FKTN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.691000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.941200E-01
Normal-vs-Stage2
6.045400E-01
Normal-vs-Stage3
1.637980E-01
Normal-vs-Stage4
4.994600E-01
Stage1-vs-Stage2
3.370200E-01
Stage1-vs-Stage3
1.423990E-02
Stage1-vs-Stage4
4.188000E-01
Stage2-vs-Stage3
2.10170000003451E-06
Stage2-vs-Stage4
4.120300E-02
Stage3-vs-Stage4
6.707500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.868000E-01
Normal-vs-AfricanAmerican
6.493200E-01
Normal-vs-Asian
4.810400E-01
Caucasian-vs-AfricanAmerican
8.278400E-01
Caucasian-vs-Asian
4.242200E-01
AfricanAmerican-vs-Asian
7.585400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.214200E-01
Normal-vs-Female
7.336800E-01
Male-vs-Female
7.381000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.118000E-01
Normal-vs-Age(41-60Yrs)
9.720000E-01
Normal-vs-Age(61-80Yrs)
5.104600E-01
Normal-vs-Age(81-100Yrs)
5.079000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.419400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.692400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.882400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.943550E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.749390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.815000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.713000E-01
Normal-vs-Daily Drinker
3.569200E-01
Normal-vs-Weekly Drinker
6.631200E-01
Normal-vs-Occasional Drinker
9.700600E-01
Normal-vs-Social Drinker
8.005400E-01
Non Drinker-vs-Daily Drinker
9.325600E-01
Non Drinker-vs-Weekly Drinker
5.259600E-01
Non Drinker-vs-Occasional Drinker
9.583900E-02
Non Drinker-vs-Social Drinker
8.676000E-02
Daily Drinker-vs-Weekly Drinker
5.070600E-01
Daily Drinker-vs-Occasional Drinker
1.016190E-01
Daily Drinker-vs-Social Drinker
5.720000E-02
Weekly Drinker-vs-Occasional Drinker
4.536600E-01
Weekly Drinker-vs-Social Drinker
2.747200E-01
Occasional Drinker-vs-Social Drinker
5.621400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.242390E-01
Normal-vs-Grade 2
2.420000E-02
Normal-vs-Grade 3
9.456000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.953800E-01
Grade 1-vs-Grade 3
3.210400E-01
Grade 1-vs-Grade 4
1.242390E-01
Grade 2-vs-Grade 3
3.191800E-01
Grade 2-vs-Grade 4
2.420000E-02
Grade 3-vs-Grade 4
9.456000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.234200E-01
Normal-vs-NonDiabetic
6.556200E-01
Diabetic-vs-NonDiabetic
3.299400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.776600E-01
Normal-vs-NoPancreatitis
6.577600E-01
Pancreatitis-vs-NoPancreatitis
9.749900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.871000E-01
Normal-vs-N1
6.189600E-01
N0-vs-N1
5.818200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.004200E-01
Normal-vs-TP53-NonMutant
8.902800E-01
TP53-Mutant-vs-TP53-NonMutant
9.101400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
